AGS cell line xenograft tumor as a suitable gastric adenocarcinoma model: growth kinetic characterization and immunohistochemistry analysis

Document Type : Original Article


1 Cancer Biology Research Center, Tehran University of Medical Sciences, Tehran, Iran

2 Research Center for Molecular and Cellular Imaging, Tehran University of Medical Sciences, Tehran, Iran

3 Vali-e-Asr Reproductive Health Research Center, Tehran University of Medical Sciences, Tehran, Iran


Objective(s): Gastric cancer is the third leading cause of cancer-related death worldwide. The overall survival rate of patients is poor because gastric cancers are usually diagnosed at the late stages. Therefore, further research is needed and appropriate research tools are required to develop novel therapeutic approaches.
Materials and Methods: Eight female athymic nude mice with a C57BL/6 background were used in this study. AGS cells were inoculated into the flank. The tumor volumes were calculated and growth curves were drawn. When the volume of the tumors reached 1000 mm3, the animals were humanely euthanized with CO2 gas. After harvesting, tumors were analyzed with Hematoxylin and Eosin (H&E) and immunohistochemistry (IHC). A pathologist confirmed tumor entity through H&E staining. Tumors were evaluated for expression of HER-2, P53, Ki-67, CD34, cytokeratin 8 (CK8), vimentin, estrogen receptor (ER), and progesterone receptor (PR) utilizing immunohistochemistry.
Results: The tumor take rate was 62.5%, mean doubling time was 40.984 d, and the latency period was 30.62 days. The H&E staining results showed highly malignant hyperchromatin epithelial cells. IHC assessment showed the mutation status of P53 gene. The expression score of the CK8 protein in the tumor cells was +3. Vimentin protein was not expressed and changes in mesenchymal phenotype were not observed. Ki-67 IHC indicated that the proliferation rate was >43% and angiogenesis was defined as high MVD.
Conclusion: The respective AGS xenograft model provides an opportunity to understand the pattern of tumor growth as well as to evaluate new gastric cancer therapies in in vivo studies.


Main Subjects

1. Jemal A, Bray F, Center M, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61:69-90.
2. National Cancer Institute. Treatment options by Stag 2015.
3. Nagini S. Carcinoma of the stomach: a review of epidemiology, pathogenesis, molecular genetics and chemoprevention. World J Gastrointest Oncol 2012; 4:156-169.
4. Li Y, Li B, Xiang CP, Zhang Y, Li YY, Wu XL. Characterization of gastric cancer models from different cell lines orthotopically constructed using improved implantation techniques. World J Gastroenterol 2012; 18: 136–143.
5. Frese, KK, Tuveson DA. Maximizing Mouse Cancer Models. Nat Rev Cancer 2007; 7:654-658.
6. Morton CL, Houghton PJ. Establishment of human tumor xenografts in immunodeficient mice. Nat Protoc 2007; 2:247-250.
7. Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG. Animal research: reporting in vivo experiments. Br J Pharmacol 2010; 160:1577-1579.
8. Kubota T. Metastatic models of human cancer xenografted in the nude mouse: the importance of orthotopic transplantation. J Cell Biochem 1994; 56:4-8.
9. Park JG, Frucht H, LaRocca RV, Bliss DP, Kurita Y, Chen TR,          et al. Characteristics of cell lines established from human gastric carcinoma. Cancer Res 1990; 50:2773-2780.
10. Suzuki T, Sekiguchi M. Gastric tumor cell lines.  Academic press 1995; 287-316.
11. Park JG, Yang HK, Kim WH, Chung JK, Kang MS, Lee JH, et al. Establishment and characterization of human gastric carcinoma cell lines. Int J Cancer 1997; 70:443-449.
12. Rygaard J, Carl O. Poulsen. Heterotransplantation of a human malignant tumour to “Nude” Mice. Acta Pathol Microbiol Scand 1969; 77:758-760.
13. Yoon YK, Kim HP, Han SW, Hur HS, Im SA, Bang YJ, et al. Combination of Egfr and Mek1/2 inhibitor shows synergistic effects by suppressing Egfr/Her3-dependent Akt activation in human gastric cancer cells. Mol Cancer Ther 2009; 8:2526-2536.
14. Xu L, Chen YL, Su XM, Wei PK. Study on nude mouse model of human gastric carcinoma constructed by using orthotopic transplantation and their biological properties. Journal of Qilu Oncology 2003; 10:476-478.
15. Bhargava S, Hotz B, Buhr HJ, Hotz HG. An orthotopic nude mouse model for preclinical research of gastric cardia cancer. Int J Colorectal Dis 2009; 24:31-9.
16. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009; 119:1420-1428.
17. Zhang X, Wu Y, Gong J, Lu Z, Zhou J, Wang X, et al. [Trastuzumab combined with chemotherapy in patients with Her2-Positive chemo-refractory advanced gastric or gastro-esophageal junction adenocarcinoma]. Zhonghua Zhong Liu Za Zhi 2014; 36:223-227.
18. Li Q, Zhang H, Tan C, Peng W, Ren G, Jia B, et al. Adhu5-Apoptin induces G2/M arrest and apoptosis in P53-mutated human gastric cancer Sgc-7901 Cells. Tumour Biol 2013; 34:3569-3577.